The Effect of Surveillance on the Outcome of Breast Cancer Patients

K Anvari; Azar Fanipakdel; Y Davoudi

International Journal of Cancer Management

The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences

Outlines

Abstract
Copyright

The Effect of Surveillance on the Outcome of Breast Cancer Patients

Author(s):

K Anvari¹,

Azar Fanipakdel^1,*,

Y Davoudi²

1Cancer Research Center, Omid Hospital ,Faculty of Medicine, Mashad University of Medical Sciences, Mashad, Iran

2Dept. of Radiology, Imam Reza Hospital, Mashad University of Medical Sciences, Mashad, Iran

International Journal of Cancer Management:Vol. 6, issue 1; e80379

Published online:Mar 30, 2013

Article type:Research Article

Received:Apr 29, 2012

Accepted:Oct 15, 2012

How to Cite:K AnvariAzar FanipakdelY DavoudiThe Effect of Surveillance on the Outcome of Breast Cancer Patients.Int J Cancer Manag.6(1):e80379.

Abstract

Background: The beginning of metastasis poorly affects the prognosis of breast cancer patients. Lung is the most frequent site of visceral metastasis, and the rate of recurrence is 10-30%. We have tried to find out if the routine Chest X Ray (CXR) could play a role for early detection of lung metastasis, during the prognosis of these patients.

Methods: The files of the breast cancer patients between 1996 to 2006 (1739 patients) have reviewed. Clinical characteristics of patients with pulmonary metastasis have recorded. Patients, who lacked imaging files or lacked an appropriate follow-up, have excluded. Data have analyzed by SPSS 11.5. The survival analyses have performed by using the Kaplan-Meier method.

Results: Fifty-six patients, median age 46, have entered into this retrospective study. Median tumor size was 4cm; median number of Lymphadenopathy (LAP) was 4. The intermediate grade has detected in 74% of patients. All patients have received adjuvant treatment. Median time from cancer diagnosis to pulmonary metastasis was 22 months. Pulmonary metastasis has detected by control CXR in 77.4% and patients' symptoms in 22.6%. Forty eight patients have received chemotherapy in metastatic phase. In 28 patients (50%), other sites of metastasis (bone, liver, and brain) have discovered. The most frequent pattern of lung recurrence was pulmonary nodule (44.6%), followed by pleural effusion (28.6%). Median survival was 27.5; median survival from pulmonary metastasis was 8 m.

Conclusion: Early detection of pulmonary metastasis by CXR did not affect patients' endpoints. None of the probable prognostic factors have shown a significant effect on patients' outcome. Despite systemic treatment, survival after metastasis is low.

Keywords

Breast cancer

Lung metastas

Surveillance

Fulltext

The Full text is available in PDF.

comments